Corbus Pharmaceuticals Holdings (CRBP) Non Operating Income (2013 - 2025)

Corbus Pharmaceuticals Holdings' Non Operating Income history runs 13 years deep, the most recent figure standing at $1.1 million for Q3 2025.

• In Q3 2025, Non Operating Income fell 37.57% year-over-year to $1.1 million; the TTM figure through Sep 2025 stood at $8.4 million (up 12.21% YoY), while the FY2024 annual figure was $8.5 million, up 1695.78% from the prior year.
• Non Operating Income for Q3 2025 stood at $1.1 million, down from $1.5 million in the prior quarter.
• The five-year high for Non Operating Income was $21.0 million in Q4 2021, with the low at -$920083.0 in Q1 2022.
• The 5-year median for Non Operating Income is $991000.0 (2024), against an average of $2.3 million.
• The sharpest annual moves came in 2021 and 2023: Non Operating Income plunged 1410.51% in 2021, then surged 2631.83% in 2023.
• Corbus Pharmaceuticals Holdings' Non Operating Income stood at $21.0 million in 2021, then plunged by 100.39% to -$82233.0 in 2022, then soared by 2631.83% to $2.1 million in 2023, then surged by 47.69% to $3.1 million in 2024, then plunged by 65.04% to $1.1 million in 2025.
• Business Quant data shows CRBP's Non Operating Income at $1.1 million in Q3 2025, $1.5 million in Q2 2025, and $2.8 million in Q1 2025.